Accelerated In-Building Coverage Deployment for OSI Pharmaceuticals

OSI Pharmaceuticals develops and commercializes new drugs that prolong or enhance the quality of life for patients with cancer, diabetes, and eye diseases. Over the years, management and administrative personnel had come to rely on BlackBerries and mobile phones with corporate coverage plans from Cingular and Sprint Nextel, but during a year-long remodeling process, the construction crew and corporate visitors to the site noticed that they had no cellular coverage inside the building. After soliciting recommendations from its wireless carriers, OSI acted on Cingular's recommendation and purchased a multi-carrier InterReach Unison Accel solution.